Abacus Medicine Pharma Services provides services that support gaining access to medicines around the world.

What we do

Licensed products


CP – Commercial Partnerships

Abacus Medicine Pharma Services has extensive knowledge and experience in managing the distribution of specialty medicines. Higher value, lower volumes of specialty medicines often do not sit well with the traditional distribution model. In addition, we are able to provide ancillary services such as labelling and packaging. Abacus Medicine Pharma Services can provide a high touch, specialty distribution service for these medicines, delivering directly to healthcare establishments in a timely and compliant manner.


CTS – Clinical trial solutions

Abacus Medicine Pharma Services provides tailored comparator sourcing solutions to support the efficient running of clinical trials for biotechnology and innovative pharmaceutical companies. As part of the Abacus Medicine Group, we have access to over 8,000 key brands across multiple European Union markets, and sophisticated market analysis tools which provides us with an unrivalled inventory and supplier network. This allows us to deliver a wide range of tailored and hybrid sourcing solutions to our clients.

Unlicensed products

MAP – Managed Access Programs

Abacus Medicine Pharma Services is a strategic partner to the pharmaceutical and biotech industry. MAPs provide a framework for a partnership where we create, implement and manage a programme on behalf of a drug manufacturer to provide access to their drug in countries where it is not commercially available. This can be either in the prelaunch or the post launch stage of the product lifecycle. Each programme is designed to meet the specific needs of the manufacturer.


ULM – Unlicensed medicines

Patients with an unmet medical need often require access to a medicine that is not commercially available in the country where they live. When we receive such a request from a healthcare professional, if we do not already have it in stock, we find a source of the medicine and ensure we deliver it, in compliance with appropriate regulations, to the relevant medical establishment ready for the patient to receive treatment.